IgG4-related disease (IgG4-RD) is a recently recognized emerging clinicopathological entity characterized by tumefactive lesions, a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells with fibrosis, and usually an elevated serum IgG4 concentration. [1] [2] [3] [4] The condition was first described in relation to the pancreas, i.e., what is now called type 1 autoimmune pancreatitis (AIP), [5] [6] [7] but is now considered to encompass various multi-organ inflammatory conditions within the category of IgG4-RD. [1] [2] [3] [4] 8 In the kidney, the most dominant feature associated with IgG4-RD is plasma cell À rich tubulointerstitial nephritis (TIN) with increased IgG4-positive plasma cells and fibrosis. 9, 10 However, various glomerular lesions, including membranous nephropathy, are also reportedly concurrent with TIN. [9] [10] [11] [12] [13] [14] In addition, several radiologically characteristic lesions within the kidney, including the renal parenchyma and pelvis, have also been shown to be diagnostic for IgG4-RD affecting the kidney, in the setting of definitively diagnosed IgG4-related lesions in extrarenal organs. 8, 11 Accordingly, the term 'IgG4-related kidney disease (IgG4-RKD)' has been proposed as a comprehensive term for the renal lesions associated with IgG4-RD. 8, 11 BRIEF OVERVIEW OF IgG4-RD The first case of AIP was described in 1961 (Sarles et al. 15 ) and the disease concept was proposed in 1995 (Yoshida et al. 16 ). It is a unique form of chronic pancreatitis assumed to have an autoimmune etiology, and is currently divided into two distinct histological types: type 1 and type 2. 7 In 2001, Hamano et al. 5 demonstrated that the serum level of IgG4 was significantly elevated in patients with sclerosing pancreatitis (now called type 1 AIP). In 2003, Kamisawa et al. 6 reported the presence of numerous IgG4-positive plasma cell infiltrates in both the pancreatic and extrapancreatic lesions of type 1 AIP and proposed a new clinicopathological entity: IgG4-related systemic disease. On the other hand, Mikulicz's disease, a clinical entity showing persistent symmetrical swelling of the lacrymal, parotid, or submandibular glands with massive infiltration of mononuclear cells, which was considered to be a subtype of Sjö-gren's syndrome, is now thought to differ from Sjögren's syndrome, as it is associated with a high serum IgG4 level and infiltration of numerous IgG4-positive plasma cells in the affected glands. 1, 17 Subsequently, clinicopathological conditions similar to those in type 1 AIP or Mikulicz's disease, i.e., a high serum IgG4 level, a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, and a favorable response to corticosteroid treatment, have been described in various organs, leading to the proposal of 'IgG4-RD' as a newly characterized systemic disease. [1] [2] [3] 8 Now, many sites/organs are considered to show IgG4-related lesions. Major organ manifestations of IgG4-RD are shown in Table 1 .
IgG4-RD mainly affects middle-aged to elderly men, many of whom have allergic conditions. 1, 3 Patients with IgG4-RD often have lesions in several organs, either synchronously or metachronously, although others may show involvement of only a single organ. [1] [2] [3] Although the clinical symptoms vary depending on the affected organ, they are relatively mild, and organ swelling may be the only diagnostic clue in many patients. IgG4-RD is diagnosed from a combination of clinical, serological, and radiological findings, along with pathological features. The feature essential for a pathological diagnosis of IgG4-RD is an increased number of infiltrating IgG4-bearing plasma cells within the involved organ(s), but other key histopathological features include a dense lymphoplasmacytic infiltrate, fibrosis arranged at least focally in a storiform pattern, and obliterative phlebitis; nonobliterative phlebitis and an increased number of eosinophils may also be associated features, [1] [2] [3] [4] although differences among organ sites may be evident. Corticosteroid is the first-line therapy for IgG4-RD and usually leads to a rapid resolution of most IgG4-RD lesions, although recurrence and relapse are frequent when corticosteroid is reduced or withdrawn. [1] [2] [3] CLINICAL FEATURES OF IgG4-RKD IgG4-RKD shows a striking male predominance (73-87%), and the average patient age is about 65 years. [9] [10] [11] [12] [13] Systemic symptoms are relatively mild, and the condition usually becomes clinically apparent when renal dysfunction and/or renal radiographic abnormalities occur, during systemic examination for extrarenal IgG4-RD or by chance. 9, 11 Most patients with IgG4-RKD have IgG4-related extrarenal lesions, the salivary glands, lacrimal glands, lymph nodes, and pancreas being frequently affected. [9] [10] [11] [12] [13] Edema may be evident in patients with IgG4-RKD accompanied by glomerular lesions or in patients with hydronephrosis due to retroperitoneal fibrosis.
LABORATORY FEATURES OF IgG4-RKD
Polyclonal hypergammaglobulinemia is a characteristic feature of IgG4-RKD. Although B30% of patients with IgG4-RD have normal serum IgG4 concentrations, 3 almost all patients with IgG4-RKD have an elevated serum IgG4 level, and 90% have an elevated serum total IgG level. 9, 11 High levels of serum total IgG and IgG4 are remarkable in many patients: in one study, the serum total IgG level exceeded 3000 mg/dl in 50% of patients and the mean serum IgG4 level was 990 mg/dl (normal o105 mg/dl). 11 Hypocomplementemia and a high serum IgE level are also characteristics, being evident in 50-70% and 70% of patients with IgG4-RKD, respectively. [9] [10] [11] [12] [13] White blood cell counts and platelet counts are within the normal ranges in most patients, but eosinophilia is often evident (shown in 33-48% of patients with IgG4-RKD). Although antinuclear antibodies and rheumatoid factors are often positive, anti-DNA, anti-SS-A, anti-SS-B, anti-Sm, and anti-RNP antibodies are usually negative. The level of C-reactive protein is usually low, and cryoglobulin, M-protein, and antineutrophil cytoplasmic antibodies are not observed. 9, 11 Although nearly half of all patients with IgG4-RKD have proteinuria (and some have hematuria), it is mild in the majority. 9, 11 Nephrotic range proteinuria is rarely detected, except when glomerular lesions such as membranous nephropathy are also present. Kidney function varies from normal to renal failure, and the development of renal dysfunction also varies from relatively acute to slowly progressive. [9] [10] [11] [12] [13] IMAGING FEATURES OF IgG4-RKD Abnormalities of the kidneys are often observed by imaging studies in patients with IgG4-RKD and this is a characteristic feature that distinguishes the disease from other types of TIN. [9] [10] [11] [12] [13] Contrast-enhanced computed tomography is the most useful radiological tool for the diagnosis of IgG4-RKD, although the use of contrast medium requires careful judgment in patients with impaired renal function. The most common finding of enhanced computed tomography is multiple low-density lesions (Figure 1 ), and in a previous study this was observed in 65% of IgG4-RKD patients examined using this modality. 11 Diffuse kidney enlargement can sometimes be recognized even by noncontrast computed tomography examination and has been reported in 20-30% of patients with IgG4-related TIN (IgG4-TIN). [9] [10] [11] Mass lesions in the kidney are relatively rare (3-27%), [9] [10] [11] but it is important to recognize them because they may resemble a malignant tumor. Histological examination of renal tissues obtained by nondirected needle biopsy or open biopsy revealed IgG4-TIN in patients with renal parenchymal radiological abnormalities, but without renal dysfunction, indicating that these radiological abnormalities are due to m i n i r e v i e w T Saeki and M Kawano: IgG4-related kidney disease IgG4-TIN. Thus, radiological examination is quite useful for the diagnosis of IgG4-TIN. [9] [10] [11] Renal pelvic lesions in IgG4-RKD appear as diffuse thickening of the pelvic wall with a smooth intraluminal surface. 11 Gallium scintigraphy and fluorodeoxyglucose positionemission tomography are helpful in identifying not only renal but also extrarenal lesions. 9, 11 As the presence of extrarenal lesions is useful for the diagnosis of IgG4-RKD, such examinations are recommended in addition to whole-body computed tomography if IgG4-RKD is suspected. 11 
PATHOLOGICAL FEATURES OF IgG4-RKD Tubulointerstitial lesions
In IgG4-RD, a dense lymphoplasmacytic infiltrate with an increased number of IgG4-positive plasma cells and fibrosis is a key feature of the histology. 4 In IgG4-RKD, the major renal parenchymal lesion is plasma cell À rich TIN with an increased number of IgG4-positive plasma cells (Figure 2 ) and fibrosis. [9] [10] [11] [12] [13] Storiform fibrosis is an irregular pattern of fibrosis resembling the spokes of a cartwheel with spindle cells radiating from the center and is considered to be a critical histopathological feature of IgG4-RD. 4 Storiform fibrosis is also often evident in IgG4-TIN, and is useful for diagnosis (Figure 3a) , 18, 19 although some patients show acute TIN with minimal fibrosis. 10, 18, 19 A unique characteristic feature of IgG4-TIN is nests of inflammatory cells with irregular fibers surrounding them. This is usually revealed by periodic acid À methenamine silver staining, and therefore it is not described in extrarenal organs. Yamaguchi et al. 19 have coined the term 'bird's-eye fibrosis' to describe this feature, because it resembles the 'bird's eye' grain pattern of maple wood (Figure 3b ). In addition to these characteristic patterns of fibrosis, eosinophil infiltration, extension of lesions into the renal capsule, a well-defined regional lesion distribution, and a marked fibrosis are positively suggestive of IgG4-TIN. 18, 19 Conversely, necrotizing angiitis, granulomatous lesions, neutrophil infiltration, and advanced tubulitis are very rare in IgG4-TIN, and their presence would essentially rule out such a diagnosis, i.e., being negatively suggestive of IgG4-TIN. 18 These positive and negative histological features are common to those in IgG4-RD. 4 Obliterative phlebitis is also a critical pathological feature of IgG4-RD, 4 although it is rarely seen in IgG4-TIN, 19 probably because of the small size of the specimens obtained by kidney needle biopsy. Immune complex deposition in the tubular basement membrane (TBM) has been documented with high frequency in immunofluorescence studies, and this is also useful in the diagnosis of IgG4-TIN. 10, 13, 19, 20 Raissian et al. 10 reported focal or diffuse immune complex deposition in the TBM in X80% of patients with IgG4-TIN. Immunofluorescence studies have detected IgG (without light chain restriction) and/or C3 (and occasionally C1q) granular deposits on the TBM in 50-80% of patients with IgG4-TIN, 10, 19, 20 and electron-dense deposits have been demonstrated in the TBM in more than 80% of patients by electron microscopy. 10 TBM deposits are found more frequently in specimens with interstitial fibrosis and occur only in areas of fibroinflammation and not in adjacent unaffected areas. 10, 19 Subclass staining of TBM deposits have revealed IgG4 and also other subclasses (mainly IgG1 and IgG3) in all cases evaluated, 19 suggesting that several types of IgG subclass might be included in the TBM immune complexes seen in IgG4-TIN.
Glomerular lesions
Although TIN is the major lesion in IgG4-RKD, some glomerular lesions have been reported to be concurrent with IgG4-TIN or IgG4-RD, [9] [10] [11] [12] [13] [14] [19] [20] [21] [22] although the occurrence of glomerular lesions in IgG4-RD could be due to chance alone. Membranous nephropathy is the most common glomerular lesion in IgG4-RKD, having been reported in 7-10% of patients with IgG4-TIN. 12, 13 Although cases of IgG4-RD in which the glomerular lesion is the sole kidney lesion without TIN are not defined as IgG4-RKD at the present time, 8, 11 patients with membranous nephropathy in the setting of IgG4-RD, but without TIN, have been reported recently. 21, 22 Alexander et al. 22 have reported that membranous nephropathy may occur in association with IgG4-RD, irrespective of the presence of TIN, and proposed a new viewpoint for the pathogenesis of IgG4-RD: membranous nephropathy is a manifestation of IgG4-RKD, in which a unique mechanism may be involved in a different manner from those of other fibro-inflammatory lesions in IgG4-RD. In membranous nephropathy associated with IgG4-RD, either with or without TIN, IgG4 deposition is usually, but not always, predominant on the glomerular basement membrane and usually concurrent with other types of IgG subclasses. 14, 21, 22 Although anti-M-type phospholipase A2 receptor antibodies, which have been demonstrated in 70% of cases of idiopathic membranous nephropathy, were negative in all cases of membranous nephropathy associated with the IgG4-RD cases evaluated, 21, 22 and there are many differences in clinical and histological features between IgG4-RKD and idiopathic membranous nephropathy, predominance of IgG4 and Th2 cytokines is common. 3, 23 The relationship of membranous nephropathy to IgG4-RD is thus interesting, and a comparative study of the two diseases might be helpful for elucidating their respective pathogeneses. Similarly, Henoch À Schonlein purpura nephritis concurrent with IgG4-TIN is of interest. 24, 25 In IgG4-RD, allergic manifestations are often observed and IgG4 is produced in response to repeated exposure to environmental antigens. 3 In previous case reports, such an allergic predisposition or response to repeated allergen exposure had been discussed as a possible cause of both the Henoch À Schonlein purpura nephritis and IgG4-TIN. 24, 25 Except for membranous nephropathy and the Henoch À Schonlein purpura nephritis, IgA nephropathy, endocapillary proliferative glomerulonephritis, membranoproliferative glomerulonephritis, and mesangial proliferative glomerulonephritis have also been reported as conditions concurrent with IgG4-TIN. [9] [10] [11] [12] As the relationship between the glomerular lesions and IgG4-RD has not been elucidated, accumulation and careful study of larger series will be necessary.
DIAGNOSIS OF IgG4-RKD
In 2011, diagnostic criteria for IgG4-TIN and a diagnostic algorithm using a set of diagnostic criteria for IgG4-RKD were proposed by a group of North America 10 and the Japanese Society of Nephrology, 11 respectively. Both sets of criteria consider serology, renal imaging, histology, and involvement of other organs as important diagnostic factors, along with exclusion of other diseases.
In diagnostic criteria for IgG4-TIN, 10 a renal histologic picture of plasma cell À rich TIN with an increased number of IgG4-positive plasma cells is essential, and at least one other feature based on imaging, serology (an elevated serum IgG4 or total IgG level), or IgG4-related involvement of another organ is required (Table 2) . Excluding pauciimmune necrotizing and crescentic glomerulonephritis, IgG4 immunohistochemical analysis had a sensitivity of 100% and a specificity of 92%. 10 In the Japanese diagnostic algorithm for IgG4-RKD (Figure 4) , 11 the presence of some kidney damage, as manifested by abnormal urinalysis parameters or urine marker(s), abnormal radiologic findings, or decreased kidney function, with either an elevated serum total IgG level, hypocomplementemia, or an elevated serum IgE level, is the first step at which IgG4-RKD should be suspected. After other diseases not associated with IgG4-RD, such as systemic lupus erythematosus or vasculitis, have been ruled out, an elevated serum IgG4 level should be confirmed. Thereafter, any characteristic radiological and histologic findings are evaluated. With regard to renal histology, dense lymphoplasmacytic infiltration with 410 infiltrating IgG4-positive plasma cells per high-power field and/or a IgG4 þ /IgG þ plasma cell ratio of 440% with fibrosis are essential features. In addition, characteristic fibrosis is considered an important diagnostic finding. Other features useful for differential diagnosis would also include positive and negative findings (see Pathologic Features section). In patients for whom renal histological data are unavailable, diagnosis of IgG4-RKD is based on the renal radiologic features characteristic of IgG4-RKD in the setting of definitively diagnosed IgG4-related lesions in organs other than the kidney.
DIFFERENTIAL DIAGNOSIS
Exclusion of various diseases that can induce TIN, including autoimmune, inflammatory, or malignant conditions, is necessary for the diagnosis of IgG4-TIN. [10] [11] [12] [13] Clinical features including hypergammaglobulinemia, hypocomplementemia, and extrarenal involvement are partly similar to those of systemic lupus erythematosus, Sjögren's syndrome, cryoglobulinemia, or sarcoidosis, and the determination of the serum IgG4 level and immunostaining for IgG4 are useful in distinguishing these diseases. However, an increase in the number of IgG4-positive plasma cells may be a feature of myeloperoxidase-antineutrophil cytoplasmic antibodyassociated vasculitis, granulomatosis with polyangitis, Churg-Strauss syndrome, multicentric Castleman's disease, lymphoproliferative disorders including malignant lymphoma, and even some inflammatory conditions. 2,3,26 Moreover, Houghton et al. 26 have reported that IgG4-positive plasma cell infiltration in the renal parenchyma may be evident even in some cases of diabetic nephropathy, lupus nephritis, and idiopathic TIN. Therefore, over-reliance on the results of IgG4 immunostaining should be avoided, and careful consideration should also be given to the clinical, imaging, and histological features. In terms of radiology, exclusion of malignant tumor, urinary tract carcinoma, or pyelonephritis is necessary.
TREATMENT AND CLINICAL COURSE OF IgG4-RKD
A rapid response to corticosteroid therapy is a characteristic feature of IgG4-RD, and corticosteroid is typically the first line of therapy, although no controlled trial has been performed and the protocol used for corticosteroid therapy has varied among countries or institutions. 1, 3 Corticosteroid also elicits a rapid response in most cases of IgG4-TIN 9,10 and few data on the efficacy of other treatments for IgG4-TIN are available.
In extrarenal organs associated with IgG4-RD, various immunosuppressants or B-cell depletion with rituximab therapy are reportedly useful in some patients with recurrent or refractory IgG4-RD. 3, 27 In Japan, the usual therapy for IgG4-RD is oral administration of prednisolone (0.6 mg/kg/ day) as induction therapy for 2-4 weeks, and then the dose is gradually tapered to a low-maintenance dose and continued for several years. 28 In a study of 19 Japanese patients with IgG4-TIN, this treatment was reported to lead to a rapid improvement of renal function, hypocomplementemia, and renal radiologic findings at 1 month after the start of therapy in 18 patients (94.7%), 9 and a recent study found that the recovery of renal function persisted for a relatively longer period (median follow-up, 34 months) under the low-dose maintenance. 29 However, recovery of renal function was not total, and irreversible renal failure requiring maintenance hemodialysis still occurred in treated patients with advanced renal damage due to IgG4-TIN. 9, 29 Renal atrophy developed in a considerable proportion of the treated patients, especially those in whom advanced renal damage had already been evident before therapy, 29 suggesting that early diagnosis and treatment for IgG4-TIN are essential. In addition, relapse of IgG4-related lesions, including kidney lesions, occurred in 20% of treated patients with IgG4-RKD during maintenance therapy. 29 In view of these reports, it appears that corticosteroid therapy with maintenance under the present system may still be insufficient, and a large-scale prospective study seems warranted to determine a more useful treatment strategy for IgG4-RKD. Interestingly, a re-decrease of the serum complement level in patients who had shown hypocomplementemia before therapy was associated with IgG4-RD relapse, suggesting that this feature may be useful for the prediction of IgG4-RKD relapse. 29 The risk of malignancies is another problem associated with IgG4-RKD. In patients with IgG4-RD, the incidence of malignancies is 3.5 times higher than that in the general population. 30 In a study involving 43 patients, 7 malignancies were diagnosed after the diagnosis of IgG4-RKD and these ultimately proved fatal in 2 patients. 29 Patients with IgG4-RKD should therefore be examined and followed up carefully in the long term for complications or the development of malignancies.
PATHOGENESIS
Although several mechanisms including autoimmunity, allergy, or innate immunity have been discussed, the role of IgG4 in IgG4-RD and the pathogenesis of IgG4-RD is poorly understood. 1, 3, 12, 13, 22 Predominance of a Th2-cell response and activation of regulatory T cells at affected sites 31 have been commonly confirmed in various organs in association with IgG4-RD; production of IL-4, IL-10, and TGF-b is also markedly increased in IgG4-TIN compared with other types of TIN. 32 Accumulation of cases and further examinations will be required to clarify the pathogenesis of IgG4-RKD.
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